Please use this identifier to cite or link to this item:
Title: Clinical usefulness of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) scale in patients with type I bipolar disorder
Author: Guilera Ferré, Georgina
Pino López, Oscar
Gómez Benito, Juana
Rojo Rodés, José Emilio
Vieta i Pascual, Eduard, 1963-
Tabarés-Seisdedos, Rafael
Segarra Martínez, Núria
Martínez-Arán, Anabel, 1971-
Franco Martín, Manuel A.
Cuesta, Manuel J.
Crespo Facorro, Benedicto
Bernardo Arroyo, Miquel
Purdon, Scot E.
Díez, Teresa
Rejas, Javier
Keywords: Trastorn bipolar
Manic-depressive illness
Issue Date: 1-Apr-2009
Publisher: BioMed Central
Abstract: Background: The relevance of persistent cognitive deficits to the pathogenesis and prognosis of bipolar disorders (BD) is understudied, and its translation into clinical practice has been limited by the absence of brief methods assessing cognitive status in Psychiatry. This investigation assessed the psychometric properties of the Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) for the detection of cognitive impairment in BD. Methods: After short training, psychiatrists at 40 outpatient clinics administered the SCIP three times over two weeks to a total of 76 consecutive type I BD admissions. Experienced psychologists also administered a comprehensive battery of standard neuropsychological instruments to clinical sample and 45 healthy control subjects. Results: Feasibility was supported by a brief administration time (approximately 15 minutes) and minimal scoring errors. The reliability of the SCIP was confirmed by good equivalence of forms, acceptable stability (ICC range 0.59 to 0.87) and adequate internal consistency (Chronbach's alpha of 0.74). Construct validity was granted by extraction of a single factor (accounting 52% of the variance), acceptable correlations with conventional neuropsychological instruments, and a clear differentiation between bipolar I and normal samples. Efficiency was also provided by the adequate sensitivity and specificity. Limitations: The sample size is not very large. The SCIP and the neurocognitive battery do not cover all potentially relevant cognitive domains. Also, sensitivity to change remains unexplored. Conclusion: With minimal training, physicians obtained a reliable and valid estimate of cognitive impairment in approximately 15 minutes from an application of the SCIP to type I BD patients.
Note: Reproducció del document publicat a:
It is part of: Health And Quality Of Life Outcomes, 2009, vol. 7, num. 28
Related resource:
ISSN: 1477-7525
Appears in Collections:Articles publicats en revistes (Psicologia Social i Psicologia Quantitativa)
Articles publicats en revistes (Psicologia Clínica i Psicobiologia)

Files in This Item:
File Description SizeFormat 
569501.pdf265.65 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons